Effect of Statin Use on Influenza Vaccine Effectiveness (scientific article)

Substantial Influenza Vaccine Effectiveness in Households With Children During the 2013-2014 Influenza Season, When 2009 Pandemic Influenza A(H1N1) Virus Predominated

Q30381731

Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013-2014 in the United States.

Q30383312

Pre-admission statin use and in-hospital severity of 2009 pandemic influenza A(H1N1) disease

Q30402302

Effectiveness of monovalent 2009 pandemic influenza A virus subtype H1N1 and 2010-2011 trivalent inactivated influenza vaccines in Wisconsin during the 2010-2011 influenza season

Q30426206

Construction of atorvastatin dose-response relationships using data from a large population-based DNA biobank

Q31106150

Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates

Q33554684

Impact of repeated vaccination on vaccine effectiveness against influenza A(H3N2) and B during 8 seasons

Q34393525

Antibody landscapes after influenza virus infection or vaccination.

Q34580640

Association between use of statins and mortality among patients hospitalized with laboratory-confirmed influenza virus infections: a multistate study

Q34634314

Development of reusable logic for determination of statin exposure-time from electronic health records

Q35082814

Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses

Q35130915

Influenza vaccine effectiveness in the United States during 2012-2013: variable protection by age and virus type

Q35531934

Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents?

Q35789870

The confounded effects of age and exposure history in response to influenza vaccination

Q36495901

Impact of Statins on Influenza Vaccine Effectiveness Against Medically Attended Acute Respiratory Illness

Q36705828

Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains

Q36854011

A Perfect Storm: Impact of Genomic Variation and Serial Vaccination on Low Influenza Vaccine Effectiveness During the 2014-2015 Season

Q36991782

Mechanisms for the anti-inflammatory effects of statins

Q37853818

Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season

Q38415770

The test-negative design for estimating influenza vaccine effectiveness

Q38427246

Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies

Q38803189

Influence of Statins on Influenza Vaccine Response in Elderly Individuals

Q38948273

Enhanced Genetic Characterization of Influenza A(H3N2) Viruses and Vaccine Effectiveness by Genetic Group, 2014-2015.

Q40670577

Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine

Q42242172

Influenza vaccine effectiveness in Wisconsin during the 2007-08 season: comparison of interim and final results

Q45848424

Reply to Fedson

Q46122043

Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season

Q46159620

Short-term atorvastatin treatment enhances specific antibody production following tetanus toxoid vaccination in healthy volunteers

Q46932696

A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season

Q47843797

The case test-negative design for studies of the effectiveness of influenza vaccine.

Q51225150

Evaluation of self-reported and registry-based influenza vaccination status in a Wisconsin cohort

Q57384993

P433

issue

P407

language of work or name

English

Q1860

P921

main subject

influenza vaccine

Q383260

P304

page(s)

1150-1158

P577

publication date

2016-07-28

P1433

published in

Journal of Infectious Diseases

Q4051141

P1476

title

Effect of Statin Use on Influenza Vaccine Effectiveness

P478

volume

214

Reverse relations

cites work (P2860)

Q93089924	A framework for research on vaccine effectiveness
Q57146553	Effect of statin use on the risk of medically attended acute respiratory illness among influenza vaccinated elderly
Q59349265	Effectiveness of inactivated influenza vaccine against laboratory-confirmed influenza pneumonia among adults aged ≥65 years in Japan
Q90574492	Factors Influencing Persistence of Diphtheria Immunity and Immune Response to a Booster Dose in Healthy Slovak Adults
Q59129922	Healthy elderly Singaporeans show no age-related humoral hyporesponsiveness nor diminished plasmablast generation in response to influenza vaccine
Q38638372	If there were a vaccine against acute myocardial infarction, would you use it?
Q59349308	Immune History and Influenza Vaccine Effectiveness
Q56517362	Immune response to influenza vaccination in the elderly is altered by chronic medication use
Q39310460	Impact of Aging and Cytomegalovirus on Immunological Response to Influenza Vaccination and Infection.
Q55515189	Impact of Dietary Cholesterol on the Pathophysiology of Infectious and Autoimmune Disease.
Q58110187	Influenza Vaccine Effectiveness and Statin Use Among Adults in the United States, 2011-2017
Q38682985	Overview of influenza vaccination policy in Beijing, China: Current status and future prospects
Q47101549	Skin immunization by microneedle patch overcomes statin-induced suppression of immune responses to influenza vaccine
Q90205172	Statin use and medically attended acute respiratory illness among influenza vaccine recipients
Q55339928	Statins increase the risk of herpes zoster: A propensity score-matched analysis.
Q28076034	Treating the host response to emerging virus diseases: lessons learned from sepsis, pneumonia, influenza and Ebola